Eva Beranová
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
- Intracerebral and Subarachnoid Hemorrhage Research
Papers in
- Neurology 10
- Long-Term Effects of COVID-19 7
- Intracerebral and Subarachnoid Hemorrhage Research 3
- Neuroinflammation and Neurodegeneration Mechanisms 2
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Journals
- The Lancet (9 papers)The Lancet Respiratory Medicine (5 papers)Nature (4 papers)EClinicalMedicine (2 papers)Neurology (2 papers)
- Partner nations
- United KingdomAustraliaItaly
In The Last Decade
Eva Beranová
37 papers receiving 4.0k citations
Eva Beranová's Hit Papers
Peers
Comparison fields: 5 of 133
- Infectious Diseases 1.6k
- Neurology 1.1k
- Rehabilitation 231
- Critical Care and Intensive Care Medicine 170
- Internal Medicine 92
Countries citing papers authored by Eva Beranová
This map shows the geographic impact of Eva Beranová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Beranová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Beranová more than expected).
Fields of papers citing papers by Eva Beranová
This network shows the impact of papers produced by Eva Beranová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Beranová. The network helps show where Eva Beranová may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 307 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 7 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 228 |
| 8 | 2018 | 214 | |
| 9 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 10 | 2016 | 163 | |
| 11 | 2019 | 145 | |
| 12 | 2017 | 129 | |
| 13 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 121 |
| 14 | 2022 | 86 | |
| 15 | 2023 | 83 | |
| 16 | 2019 | 71 | |
| 17 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 18 | 2006 | 62 | |
| 19 | 2023 | 56 | |
| 20 | 2023 | 35 |
About Eva Beranová
Eva Beranová is a scholar working on Neurology, Infectious Diseases, Critical Care and Intensive Care Medicine, Neurology and Immunology, having authored 37 papers that have together received 4.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Long-Term Effects of COVID-19 (7 papers), COVID-19 Clinical Research Studies (6 papers), interferon and immune responses (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Intensive Care Unit Cognitive Disorders (2 papers) and Machine Learning in Bioinformatics (1 paper). The work is most often cited by research in Infectious Diseases (1.6k citations), Neurology (1.1k citations), Rehabilitation (231 citations), Critical Care and Intensive Care Medicine (170 citations) and Internal Medicine (92 citations). Eva Beranová has collaborated with scholars based in United Kingdom, Australia and Italy. Their work appears in journals such as The Lancet, The Lancet Respiratory Medicine, Nature, EClinicalMedicine and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.